Source:http://linkedlifedata.com/resource/pubmed/id/21105526
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5070
|
pubmed:dateCreated |
2010-11-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
212
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1597-8
|
pubmed:meshHeading |
pubmed-meshheading:21105526-Administration, Oral,
pubmed-meshheading:21105526-Chelating Agents,
pubmed-meshheading:21105526-Copper,
pubmed-meshheading:21105526-Feces,
pubmed-meshheading:21105526-Hepatolenticular Degeneration,
pubmed-meshheading:21105526-Humans,
pubmed-meshheading:21105526-Pentetic Acid
|
pubmed:year |
1966
|
pubmed:articleTitle |
New oral chelating agent for treatment of Wilson's disease.
|
pubmed:affiliation |
Department of Neurology, University of California Medical Center, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|